Key result
Circulating vaccine-derived poliovirus outbreak in Papua New Guinea prompts nationwide immunization after 26 confirmed cases.
Observational (n=26)
Answers are grounded in this paper and cite their sources.
The detection of a cVDPV1 outbreak in Papua New Guinea underscores the vulnerability of underimmunized populations and the need for rigorous acute flaccid paralysis surveillance.
Circulating Vaccine-Derived Poliovirus Type 1 and Outbreak Response — Papua New Guinea, 2018 Mathias Bauri, MPH, MBA1; Amanda L. Wilkinson, PhD2; Berry Ropa, MPH1; Keith Feldon, MPH3; Cynthia J. Snider, PhD2; Abhijeet Anand, MBBS2; Graham Tallis, MPH4; Liliane Boualam, MPH4; Varja Grabovac, MSc5; Tigran Avagyan, MD5; Mohammad S. Reza, MPH6; Dessie Mekonnen, PhD6; Zaixing Zhang, MD6; Bruce R. Thorley, PhD7; Hiroyuki Shimizu, PhD8; Lea Necitas G. Apostol, PhD9; Yoshihiro Takashima, MD, PhD5
No takes yet. Share an insight, caveat, or question.
Bauri et al. (2019) conducted an observational in Circulating vaccine-derived poliovirus type 1 (cVDPV1) (n=26). cVDPV1 outbreak and supplementary immunization activities was evaluated on Confirmed cases of cVDPV1. An outbreak of circulating vaccine-derived poliovirus type 1 in Papua New Guinea resulted in 26 confirmed cases and prompted nationwide supplementary immunization activities.
Synapse has enriched 10 related papers. Consider them for comparative context: